Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
-
>20 year‑old venous leg ulcers show dramatic healing and pain elimination with revyveThermoreversible revyve transforms deep tunneling wound care, delivering 90% wound volume reductionrevyve...
-
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
-
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
-
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
-
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
-
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
-
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
-
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
-
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference